Table 4.
Multivariate analyses for patients with ESCC.
| HR (95% CI) | P value | |
|---|---|---|
| Tumor length (cm) | 0.603 | |
| ≤3 | 1.000 | |
| >3 | 1.075 (0.818–1.412) | |
| Vessel involvement | 0.742 | |
| Negative | 1.000 | |
| Positive | 1.060 (0.747–1.505) | |
| Perineural invasion | 0.077 | |
| Negative | 1.000 | |
| Positive | 1.341 (0.968–1.857) | |
| TNM stage | <0.001 | |
| I | 1.000 | |
| II | 1.586 (1.048–2.400) | 0.029 |
| III | 2.220 (1.456–3.384) | <0.001 |
| I stage | <0.001 | |
| I0 | 1.000 | |
| I1 | 1.543 (1.076–2.214) | 0.018 |
| I2 | 2.356 (1.602–3.466) | <0.001 |
| I3 | 3.594 (2.363–5.467) | <0.001 |
| CRP (mg/L) | 0.493 | |
| ≤10.0 | 1.000 | |
| >10.0 | 1.151 (0.770–1.719) | |
| NLR | 0.786 | |
| ≤3.5 | 1.000 | |
| >3.5 | 1.050 (0.740–1.488) | |
| PLR | 0.065 | |
| ≤150 | 1.000 | |
| >150 | 1.440 (0.978–2.121) |